Results
eNauka >
Results >
Cost-utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle-income economy setting
| Title: | Cost-utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle-income economy setting | Authors: | Obrenovic, Svetlana; Folic, Marko M   ; Folic, Nevena D ; Jankovic, Slobodan M |
Issue Date: | 2025 | Publication: | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | ISSN: | 0306-5251 British Journal of Clinical Pharmacology Search Idenfier |
Type: | Article | DOI: | 10.1002/bcp.70172 | WoS-ID: | 001530850600001 | Scopus-ID: | 2-s2.0-105011212837 | URI: | https://enauka.gov.rs/handle/123456789/991240 | Project: | Serbian Ministry of Science, Technological Development and Innovations [175007, 451-03-137/2025-03/200111] | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21M21 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.